Загрузка...
Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy
Introduction: Venous thromboembolism (VTE) is a potential risk of estrogen therapy. However, data show an improvement in the quality of life for transgender people who use feminizing hormone therapy. With few transgender-specific data, guidance may be drawn from cisgender (nontransgender) data, with...
Сохранить в:
| Опубликовано в: : | J Blood Med |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628137/ https://ncbi.nlm.nih.gov/pubmed/31372078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S166780 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|